Therapeutic Vaccines for Head and Neck Squamous Cell Carcinoma and Nasopharyngeal Carcinoma

<b>Background and Objectives:</b> Recent evidence demonstrates additional survival benefit of immune checkpoint inhibitor (ICI) therapy in the treatment of head and neck squamous cell carcinoma (HNSCSC) and nasopharyngeal carcinoma (NPC). However, overall outcomes remain relatively stagnant despite...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Michael Baliton, Duha Alfatlawi, Shirin Attarian, Rupali Nabar, Victoria Villaflor
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2026-04-01
Serija:	Vaccines
Teme:	head and neck squamous cell carcinoma (HNSCC) Epstein–Barr virus (EBV) human papilloma virus (HPV) immunotherapy therapeutic vaccine mRNA vaccine
Online dostop:	https://www.mdpi.com/2076-393X/14/4/321
Oznake:	Označite Brez oznak, prvi označite!